A Q4 third immunology program announcement has to happen tomorrow or 12/31/25 in order for ENTA management to fulfil their promised timeline. If it doesn't happen in Q4, are shareholders to read into this?
It depends on how long of a delay there is. I would be fine if the announcement comes in January.